BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Recruiting · NCT04421820 · Registry updated 2026-05-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, cholangiocarcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, gastric cancer, gastric neoplasm, intestinal disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, rectal disorder, stomach disorder | Recruiting | Phase 1 / Phase 2 | 2026-05-18 | NCT04421820 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bold Therapeutics, Inc. | 1 |
24 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.